This bill seeks to amend the Public Health Service Act to strengthen prohibitions against the sale or transactions involving human fetal tissue. It specifically revises the definition of "valuable consideration" within Section 498B(e)(3) of the Act, aiming to close potential loopholes. The expanded definition now encompasses a wide range of exchanges, including any payment made, gifts, honoraria, and any waived, reduced, or delayed fees. Crucially, it explicitly includes payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue. This comprehensive redefinition intends to prevent any financial transactions related to human fetal tissue.